MRS study of meningeal hemangiopericytoma and edema: A comparison with meningothelial meningioma

Righi,Valeria; Tugnoli,Vitaliano; Mucci,Adele; Bacci,Antonella; Bonora,Sergio; Schenetti,Luisa

doi:10.3892/or.2012.1919

MRS study of meningeal hemangiopericytoma and edema: A comparison with meningothelial meningioma

Authors:
- Valeria Righi
- Vitaliano Tugnoli
- Adele Mucci
- Antonella Bacci
- Sergio Bonora
- Luisa Schenetti
View Affiliations

Affiliations: Department of Biochemistry ‘G. Moruzzi’, University of Bologna, I-40126 Bologna, Italy, Department of Chemistry, University of Modena and Reggio Emilia, I-41125 Modena, Italy, Division of Neuroradiology, Department of Neuroscience, University of Bologna, I-40139 Bologna, Italy
Published online on: July 19, 2012 https://doi.org/10.3892/or.2012.1919
Pages: 1461-1467

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Intracranial hemangiopericytomas (HPCs) are rare tumors and their radiological appearance resembles that of meningiomas, especially meningothelial meningiomas. To increase the knowledge on the biochemical composition of this type of tumor for better diagnosis and prognosis, we performed a molecular study using ex vivo high resolution magic angle spinning (HR-MAS) magnetic resonance spectroscopy (MRS) perfomed on HPC and peritumoral edematous tissues. Moreover, to help in the discrimination between HPC and meningothelial meningioma we compared the ex vivo HR-MAS spectra of samples from one patient with HPC and 5 patients affected by meningothelial meningioma. Magnetic resonance imaging (MRI), in vivo localized single voxel 1H-MRS was also performed on the same patients prior to surgery and the in vivo and ex vivo MRS spectra were compared. We observed the presence of OH-butyrate, together with glucose in HPC and a low amount of N-acetylaspartate in the edema, that may reflect neuronal alteration responsible for associated epilepsy. Many differences between HPC and meningothelial meningioma were identified. The relative ratios of myo-inositol, glucose and gluthatione with respect to glutamate are higher in HPC compared to meningioma; whereas the relative ratios of creatine, glutamine, alanine, glycine and choline-containing compounds with respect to glutamate are lower in HPC compared to meningioma. These data will be useful to improve the interpretation of in vivo MRS spectra resulting in a more accurate diagnosis of these rare tumors.

View Figures

View References

1	Espat NJ, Lewis JJ, Leung D, et al: Conventional hemangiopericytoma: modern analysis of outcome. Cancer. 95:1746–1751. 2002. View Article : Google Scholar : PubMed/NCBI
2	Koch M, Nielsen GP and Yoon SS: Malignant tumors of blood vessels: angiosarcomas, hemangioendotheliomas, and hemangiopericytomas. J Surg Oncol. 97:321–329. 2008. View Article : Google Scholar : PubMed/NCBI
3	Mena H, Ribas JL, Pezeshkpour GH, Cowan DN and Parisi JE: Hemangiopericytoma of the central nervous system: a review of 94 cases. Hum Pathol. 22:84–91. 1991. View Article : Google Scholar : PubMed/NCBI
4	Scheithauer BW, Fuller GN and VandenBerg SR: The 2007 WHO classification of tumors of the nervous system: controversies in surgical neuropathology. Brain Pathol. 18:307–316. 2007. View Article : Google Scholar : PubMed/NCBI
5	Wu W, Shi JX, Cheng HL, et al: Hemangiopericytomas in the central nervous system. J Clin Neurosci. 16:519–523. 2009. View Article : Google Scholar : PubMed/NCBI
6	Jääskeläinen J, Louis DN, Paulus W and Haltia MJ: Haemangiopericytoma. Pathology and Genetics of the Nervous System Tumors. Kleihues P and Cavenee WK: WHO Classification of Tumors. IARC Press; Lyon: pp. 190–192. 2000
7	Kim JH, Jung HW, Kim YS, et al: Meningeal hemangiopericytomas: long-term outcome and biological behavior. Surg Neurol. 59:47–54. 2003. View Article : Google Scholar : PubMed/NCBI
8	Kleihaus P, Louis DN, Burger PC, et al: The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol. 61:215–229. 2002.
9	Galanis E, Buckner JC, Scheithauer BW, et al: Management of recurrent meningeal hemangiopericytoma. Cancer. 82:1915–1920. 1998. View Article : Google Scholar : PubMed/NCBI
10	Fountas KN, Kapsalaki E, Kassam M, et al: Management of intracranial meningeal hemangiopericytomas: outcome and experience. Neurosurg Rev. 29:145–153. 2006. View Article : Google Scholar : PubMed/NCBI
11	Sundaram C, Uppin SG, Uppin MS, et al: A clinicopathological and immunohistochemical study of central nervous system hemangiopericytomas. J Clin Neurosci. 17:469–472. 2010. View Article : Google Scholar : PubMed/NCBI
12	Akiyama M, Sakai H, Onoue H, Miyazaki Y and Abe T: Imaging intracranial hemangiopericytomas: study of seven cases. Neuroradiology. 46:194–197. 2004. View Article : Google Scholar : PubMed/NCBI
13	Sibtain NA, Butt S and Connor SE: Imaging features of central nervous system hemangiopericytomas. Eur Radiol. 17:1685–1693. 2007. View Article : Google Scholar : PubMed/NCBI
14	Tashjian VS, Khanlou N, Vinters HV, et al: Hemangiopericytoma of the cerebello pontine angle: a case report and review of the literature. Surg Neurol. 72:290–295. 2009. View Article : Google Scholar : PubMed/NCBI
15	Soyuer S, Chang EL, Selek U, et al: Intracranial meningeal hemangiopericytoma: the role of radiotherapy: report of 29 cases and review of the literature. Cancer. 100:1491–1497. 2004. View Article : Google Scholar : PubMed/NCBI
16	Olson C, Yen CP, Schlesinger D and Sheehan J: Radiosurgery for intracranial hemangiopericytoma: outcomes after initial and repeat Gamma Knife surgery. J Neurosurgery. 112:133–139. 2010. View Article : Google Scholar : PubMed/NCBI
17	Rutkowski MJ, Sughrue ME, Kane AJ, et al: Predictors of mortality following treatment of intracranial hemangiopericytoma. Neurosurgery. 113:340–351. 2010.
18	Barba I, Moreno A, Martinez-Pérez I, et al: Magnetic resonance spectroscopy of brain hemangiopericytomas: high myoinositol concentrations and discrimination from meningiomas. J Neurosurg. 94:55–60. 2001. View Article : Google Scholar : PubMed/NCBI
19	Fortuniak J, Jaskólski DJ, Stefańczyk L, Zawirski M and Gajewicz W: Magnetic resonance imaging of rare intracranial neoplasms - role of the in vivo 1 h spectroscopy in the radiological differential diagnostics. Cen Eur Neurosurg. 71:181–188. 2010. View Article : Google Scholar : PubMed/NCBI
20	Cho YD, Choi GH, Lee SP and Kim JK: (1)H-MRS metabolic patterns for distinguishing between meningiomas and other brain tumors. Magn Reson Imaging. 21:663–672. 2003. View Article : Google Scholar : PubMed/NCBI
21	Hattingen E, Pilatus U, Good C, et al: An unusual intraventricular haemangiopericytoma: MRI and spectroscopy. Neuroradiology. 45:386–389. 2003. View Article : Google Scholar : PubMed/NCBI
22	Beckonert O, Coen M, Keun HC, et al: High-resolution magic-angle-spinning NMR spectroscopy for metabolic profiling of intact tissue. Nat Protoc. 5:1019–1032. 2010. View Article : Google Scholar : PubMed/NCBI
23	DeFeo EM and Cheng LL: Charactrizing human cancer metabolomics by ex vivo 1HRMAS MRS. Technol Cancer Res Treat. 9:381–391. 2010. View Article : Google Scholar : PubMed/NCBI
24	Moestue S, Sitter B, Bathen TF, Tessem MB and Gribbestad IS: HR MAS MR spectroscopy in metabolic characterization of cancer. Curr Top Med Chem. 11:2–26. 2011. View Article : Google Scholar : PubMed/NCBI
25	Ricci R, Bacci A, Tugnoli V, et al: Metabolic findings on 3T ¹H-MR spectroscopy in peritumoral brain edema. Am J Neuroradiol. 28:1287–1291. 2007.
26	Chernov MF, Kubo O, Hayashi M, et al: Proton MRS of the peritumoral brain. J Neurol Sci. 228:137–142. 2005. View Article : Google Scholar : PubMed/NCBI
27	Louis DN, Ohgaki H, Wiestler OD, et al: The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
28	Bax A: A spatially selective composite 90° radiofrequency pulse. J Magn Reson. 65:142–145. 1985.
29	Meiboom S and Gill D: Modified spin-echo method for measuring nuclear relaxation time. Rev Sci Instrum. 20:688–691. 1958. View Article : Google Scholar
30	Wu D, Chen A and Johnson CS Jr: An improved diffusion ordered spectroscopy experiment incorporating bipolar gradient pulses. Magn Reson Series A. 115:260–264. 1995. View Article : Google Scholar
31	Jeener J: Pulse pair techniques in high resolution NMR. Ampere International Summer School; Basko Polje: 1971
32	Aue WP, Bartholdi E and Ernst RR: Two-dimensional spectroscopy. Application to nuclear magnetic resonance. J Chem Phys. 64:2229–2246. 1976. View Article : Google Scholar
33	Braunschweiler L and Ernst RR: Coherence transfer by isotropic mixing: application to proton correlation spectroscopy. J Magn Reson. 53:521–528. 1983.
34	Bax A and Davis DG: MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy. J Magn Res. 65:355–360. 1985.
35	Bodenhausen G and Ruben DJ: Natural abundance nitrogen-15 NMR by enhanced eteronuclear spectroscopy. Chem Phys Lett. 69:185–189. 1980. View Article : Google Scholar
36	Fan TMW: Metabolite profiling by one- and two-dimensional NMR analysis of complex mixtures. Prog Nuc Mag Res Spec. 28:161–219. 1996. View Article : Google Scholar
37	Wishart DS, Tzur D, Knox C, et al: HMDB: the human metabolome database. Nucleic Acids Res. 35:D521–D526. 2007. View Article : Google Scholar : PubMed/NCBI
38	Opstad KS, Wright AJ, Bell BA, et al: Correlations between in vivo ¹H MRS and ex vivo ¹H HRMAS metabolite measurements in adult human gliomas. J Magn Reson Imag. 31:289–297. 2010.
39	Harting I, Jost G, Hacke N and Hartmann M: Magnetic resonance spectroscopy of brain tumours. Nervenarzt. 76:403–417. 2005.PubMed/NCBI
40	Kashiwaya Y, Pawlosky R, Markis W, et al: A ketone ester diet increases brain malonyl-CoA and uncoupling proteins 4 and 5 while decreasing food intake in the normal Wistar Rat. J Biol Chem. 285:25950–25956. 2010. View Article : Google Scholar : PubMed/NCBI
41	Yudkoff M, Daikhin Y, Melø TM, et al: The ketogenic diet and brain metabolism of amino acids: relationship to the anticonvulsant effect. Annul Rev Nutr. 27:415–430. 2007. View Article : Google Scholar : PubMed/NCBI
42	Skinner R, Trujillo A, Ma X and Beierle EA: Ketone bodies inhibit the viability of human neuroblastoma cells. J Pediatr Surg. 44:212–216. 2009. View Article : Google Scholar : PubMed/NCBI
43	Suzuki M, Suzuki M, Kitamura Y, et al: β-hydroxybutyrate, a cerebral function improving agent, protects rat brain against ischemic damage caused by permanent and transient focal cerebral ischemia. Jpn J Pharmacol. 89:36–43. 2002.
44	Chernov MF, Kawamata T, Amano K, et al: Possible role of single-voxel (1)H-MRS in differential diagnosis of suprasellar tumors. J Neurooncol. 91:191–198. 2009. View Article : Google Scholar : PubMed/NCBI
45	Demougeot C, Garnier P, Mossiat C, et al: N-Acetylaspartate, a marker of both cellular dysfunction and neuronal loss: its relevance to studies of acute brain injury. J Neurochem. 77:408–415. 2001. View Article : Google Scholar
46	Moffett JR, Ross B, Arun P, et al: N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Prog Neurobiol. 81:89–131. 2007. View Article : Google Scholar
47	Rigotti DJ, Inglese M and Gonen O: Whole-brain N-acetylaspartate as a surrogate marker of neuronal damage in diffuse neurologic disorders. Am J Neuroradiol. 28:1843–1849. 2007.
48	Tugnoli V, Schenetti L, Mucci A, et al: Ex vivo HR-MAS MRS of human meningiomas: a comparison with in vivo ¹H MR spectra. Int J Mol Med. 18:859–869. 2006.
49	Monleon D, Morales JM, Gonzalez-Darder J, et al: Benign and atypical meningioma metabolic signatures by high-resolution magic-angle spinning molecular profiling. J Proteome Res. 7:2882–2888. 2008. View Article : Google Scholar : PubMed/NCBI